Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study
2011

Essential Fatty Acids for Treating Premenstrual Syndrome

Sample size: 120 publication 10 minutes Evidence: moderate

Author Information

Author(s): Edilberto A Rocha Filho, José C Lima, João S Pinho Neto, Ulisses Montarroyos

Primary Institution: Federal University of Pernambuco

Hypothesis

Can polyunsaturated fatty acids effectively treat premenstrual syndrome (PMS) and affect prolactin and cholesterol levels?

Conclusion

The study found that essential fatty acids significantly reduced PMS symptoms, especially at a 2-gram dose, without affecting prolactin or cholesterol levels.

Supporting Evidence

  • Significant reductions in PMS symptoms were observed in both treatment groups compared to placebo.
  • The 2-gram dose showed greater symptom improvement than the 1-gram dose.
  • No significant changes in prolactin or cholesterol levels were found after treatment.

Takeaway

Women with PMS can feel better by taking certain fatty acids, and taking more can help even more, but it doesn't change their hormone levels.

Methodology

A randomized, double-blind, placebo-controlled study with 120 women divided into three groups receiving different doses of essential fatty acids or placebo over six months.

Potential Biases

Potential biases were minimized through rigorous inclusion criteria, but the placebo effect may have influenced results.

Limitations

The study had a small number of participants who were excluded due to specific health conditions, which may limit generalizability.

Participant Demographics

Women aged 16-49 with regular menstrual cycles, diagnosed with PMS or PMDD.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-4755-8-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication